CF PHARMTECH (02652) spent 384,100 Hong Kong dollars to repurchase 12,000 shares on January 14th.
Changfeng pharmaceutical (02652) issued an announcement, on January 14, 2026, the company spent 384,100 Hong Kong dollars to repurchase 12,000 shares, with a repurchase price of 31.98-32.22 Hong Kong dollars per share.
CF PHARMTECH (02652) has announced that on January 14, 2026, the company spent HK$384,100 to repurchase 12,000 shares at a repurchase price of HK$31.98-32.22 per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
